Evidence map›Paper›PMID 22613092›Full record

ReviewCurrent opinion in immunology2012

Protection versus pathology in tuberculosis: recent insights.

Andrea M Cooper, Egidio Torrado

Abstract readReview
In one paragraph

Review in Current opinion in immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Immunometabolism of Myeloid-Derived Suppressor Cells: Implications forInternational journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review.Frontiers in cellular and infection microbiology · 2021
    Review
  8. Article
  9. Frontiers in microbiology · 2017
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Commonly administered bacille Calmette-Guerin strains induce comparable immune response.International journal of clinical and experimental medicine · 2015
    Article
  15. Novel vaccination strategies against tuberculosis.Cold Spring Harbor perspectives in medicine · 2014
    Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrea M CooperThe Trudeau Institute, Inc. 154 Algonquin Ave., Saranac Lake, NY 12983, United States. acooper@trudeauinstitute.org
Egidio Torrado

Funding

T cell memory to TB in the lungP01AI046530 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 1999 to 2013
$22.2M
T cell memory to TB in the lungR01AI069121 · NIAID · TRUDEAU INSTITUTE, INC. · PI COOPER, ANDREA M · 2008 to 2012
$2.3M
T cell responses to chronic bacterial infectionR01AI073564 · NIAID · TRUDEAU INSTITUTE, INC. · PI COOPER, ANDREA M, WINSLOW, GARY M. · 2008 to 2012
$2.3M
The role of IL-12p40 in the response of pulmonary dendritic cells to tuberculosisR01AI067723 · NIAID · TRUDEAU INSTITUTE, INC. · PI COOPER, ANDREA M · 2006 to 2010
$2.2M
NIAID NIH HHS AI046530NIAID NIH HHS AI067723NIAID NIH HHS AI069121NIAID NIH HHS AI73564NIAID NIH HHS P01 AI046530NIAID NIH HHS R01 AI067723NIAID NIH HHS R01 AI069121NIAID NIH HHS R01 AI073564
6 · The paper itself

Abstract

Recent studies have revisited the roles of prime players in the immune response to tuberculosis (TB) and have highlighted novel functions of these players. Specifically, immunoregulatory mechanisms mediated by IFNγ have been delineated as well as a novel role for neutrophils in promoting antigen presentation. New insights into the interaction between the bacterium and phagocyte indicate that the bacterium actively promotes phagocyte necrosis rather than apoptosis and that this impacts generation of the acquired response. There are also many new examples of how the phagocyte responds to the bacteria and how it mediates control. The phenotype of protective T cells is also being re-examined. These developments provide promise for improved vaccine design and highlight the complexity of this disease.

Indexed as

Adaptive ImmunityAnimalsHumansImmune SystemImmunity, InnateTuberculosis, Pulmonary

Identifiers

PMID22613092
PMCPMC3423558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.